<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2025, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 09 Apr 2025 17:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies</title>
   <link>http://www.streetinsider.com/Press+Releases/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, April  09, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (“&lt;strong&gt;Evome&lt;/strong&gt;”, the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announced the resignation of Michael Dalsin as Chairman of the Board of Directors. Mr. Chris Heath will remain on the Board and continues to work to capture shareholder value in the various assets held by Evome.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;“As a large shareholder, I joined the board to get a clear understanding of the state of affairs, survey the totality of the circumstances, and see what could be done to maximize the outcome for shareholders,” said Mr. Dalsin. “The current economic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</guid>
   <pubDate>Wed, 09 Apr 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies</title>
   <link>http://www.streetinsider.com/Press+Releases/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, April  09, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (“&lt;strong&gt;Evome&lt;/strong&gt;”, the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announced the resignation of Michael Dalsin as Chairman of the Board of Directors. Mr. Chris Heath will remain on the Board and continues to work to capture shareholder value in the various assets held by Evome.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;“As a large shareholder, I joined the board to get a clear understanding of the state of affairs, survey the totality of the circumstances, and see what could be done to maximize the outcome for shareholders,” said Mr. Dalsin. “The current economic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</guid>
   <pubDate>Wed, 09 Apr 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies</title>
   <link>http://www.streetinsider.com/Press+Releases/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, April  09, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (“&lt;strong&gt;Evome&lt;/strong&gt;”, the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announced the resignation of Michael Dalsin as Chairman of the Board of Directors. Mr. Chris Heath will remain on the Board and continues to work to capture shareholder value in the various assets held by Evome.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;“As a large shareholder, I joined the board to get a clear understanding of the state of affairs, survey the totality of the circumstances, and see what could be done to maximize the outcome for shareholders,” said Mr. Dalsin. “The current economic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</guid>
   <pubDate>Wed, 09 Apr 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies</title>
   <link>http://www.streetinsider.com/Press+Releases/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, April  09, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (“&lt;strong&gt;Evome&lt;/strong&gt;”, the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announced the resignation of Michael Dalsin as Chairman of the Board of Directors. Mr. Chris Heath will remain on the Board and continues to work to capture shareholder value in the various assets held by Evome.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;“As a large shareholder, I joined the board to get a clear understanding of the state of affairs, survey the totality of the circumstances, and see what could be done to maximize the outcome for shareholders,” said Mr. Dalsin. “The current economic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</guid>
   <pubDate>Wed, 09 Apr 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, April  09, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (“&lt;strong&gt;Evome&lt;/strong&gt;”, the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announced the resignation of Michael Dalsin as Chairman of the Board of Directors. Mr. Chris Heath will remain on the Board and continues to work to capture shareholder value in the various assets held by Evome.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;“As a large shareholder, I joined the board to get a clear understanding of the state of affairs, survey the totality of the circumstances, and see what could be done to maximize the outcome for shareholders,” said Mr. Dalsin. “The current economic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</guid>
   <pubDate>Wed, 09 Apr 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, April  09, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (“&lt;strong&gt;Evome&lt;/strong&gt;”, the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announced the resignation of Michael Dalsin as Chairman of the Board of Directors. Mr. Chris Heath will remain on the Board and continues to work to capture shareholder value in the various assets held by Evome.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;“As a large shareholder, I joined the board to get a clear understanding of the state of affairs, survey the totality of the circumstances, and see what could be done to maximize the outcome for shareholders,” said Mr. Dalsin. “The current economic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</guid>
   <pubDate>Wed, 09 Apr 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, April  09, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (“&lt;strong&gt;Evome&lt;/strong&gt;”, the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announced the resignation of Michael Dalsin as Chairman of the Board of Directors. Mr. Chris Heath will remain on the Board and continues to work to capture shareholder value in the various assets held by Evome.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;“As a large shareholder, I joined the board to get a clear understanding of the state of affairs, survey the totality of the circumstances, and see what could be done to maximize the outcome for shareholders,” said Mr. Dalsin. “The current economic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</guid>
   <pubDate>Wed, 09 Apr 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, April  09, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (“&lt;strong&gt;Evome&lt;/strong&gt;”, the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announced the resignation of Michael Dalsin as Chairman of the Board of Directors. Mr. Chris Heath will remain on the Board and continues to work to capture shareholder value in the various assets held by Evome.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;“As a large shareholder, I joined the board to get a clear understanding of the state of affairs, survey the totality of the circumstances, and see what could be done to maximize the outcome for shareholders,” said Mr. Dalsin. “The current economic</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Michael+Dalsin+Resigns+as+Chairman+of+the+Board+of+Directors+of+Evome+Medical+Technologies/24621539.html</guid>
   <pubDate>Wed, 09 Apr 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Provides Market Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  28, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;” or “&lt;strong&gt;Evome&lt;/strong&gt;”) (TSXV: EVMT) is providing an update to shareholders today.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;As important background:&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Evome generates revenue from three main revenue lines:&lt;/p&gt;  &lt;ol&gt;&lt;li&gt;“&lt;strong&gt;DaMar&lt;/strong&gt;”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“&lt;strong&gt;DaMar&lt;/strong&gt;”) offers contract manufacturing to a highly concentrated group of customers that then sell those products under their own brand name.&lt;br/&gt;&lt;/li&gt;&lt;li&gt;“&lt;strong&gt;Biodex&lt;/strong&gt;”. Biodex Medical Systems, Inc. (“&lt;strong&gt;Biodex&lt;/strong&gt;”) is a branded medical device business with approximately 50% of revenue originating from international distributors and the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Evome+Medical+Technologies+Provides+Market+Update/24567378.html</guid>
   <pubDate>Fri, 28 Mar 2025 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.08186959</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20093211</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six</title>
   <link>http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Appoints+Michael+Dalsin+as+Chairman+of+the+Board+of+Directors%3B+Increases+Size+of+Board+to+Six/24506444.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  17, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announces the appointment of Michael Dalsin as Chairman of the Board of Directors. Kenneth Kashkin, MD will take the role of Vice-Chairman. Bill Garbarini will retain his role as COO while stepping off the Board of Directors. Chris Heath was also appointed as a new Director increasing the size of the Board of Directors from five to six.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Mr. Dalsin is best known in Canada as the former Chairman of Convalo Health International, Corp. (“&lt;strong&gt;Convalo&lt;/strong&gt;”) and Patient Home Monitoring</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Appoints+Michael+Dalsin+as+Chairman+of+the+Board+of+Directors%3B+Increases+Size+of+Board+to+Six/24506444.html</guid>
   <pubDate>Mon, 17 Mar 2025 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16742673</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26513355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00287878</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six</title>
   <link>http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Appoints+Michael+Dalsin+as+Chairman+of+the+Board+of+Directors%3B+Increases+Size+of+Board+to+Six/24506444.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  17, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announces the appointment of Michael Dalsin as Chairman of the Board of Directors. Kenneth Kashkin, MD will take the role of Vice-Chairman. Bill Garbarini will retain his role as COO while stepping off the Board of Directors. Chris Heath was also appointed as a new Director increasing the size of the Board of Directors from five to six.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Mr. Dalsin is best known in Canada as the former Chairman of Convalo Health International, Corp. (“&lt;strong&gt;Convalo&lt;/strong&gt;”) and Patient Home Monitoring</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Appoints+Michael+Dalsin+as+Chairman+of+the+Board+of+Directors%3B+Increases+Size+of+Board+to+Six/24506444.html</guid>
   <pubDate>Mon, 17 Mar 2025 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16742673</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26513355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00287878</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six</title>
   <link>http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Appoints+Michael+Dalsin+as+Chairman+of+the+Board+of+Directors%3B+Increases+Size+of+Board+to+Six/24506444.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  17, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announces the appointment of Michael Dalsin as Chairman of the Board of Directors. Kenneth Kashkin, MD will take the role of Vice-Chairman. Bill Garbarini will retain his role as COO while stepping off the Board of Directors. Chris Heath was also appointed as a new Director increasing the size of the Board of Directors from five to six.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Mr. Dalsin is best known in Canada as the former Chairman of Convalo Health International, Corp. (“&lt;strong&gt;Convalo&lt;/strong&gt;”) and Patient Home Monitoring</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Appoints+Michael+Dalsin+as+Chairman+of+the+Board+of+Directors%3B+Increases+Size+of+Board+to+Six/24506444.html</guid>
   <pubDate>Mon, 17 Mar 2025 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16742673</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26513355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00287878</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six</title>
   <link>http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Appoints+Michael+Dalsin+as+Chairman+of+the+Board+of+Directors%3B+Increases+Size+of+Board+to+Six/24506444.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  17, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announces the appointment of Michael Dalsin as Chairman of the Board of Directors. Kenneth Kashkin, MD will take the role of Vice-Chairman. Bill Garbarini will retain his role as COO while stepping off the Board of Directors. Chris Heath was also appointed as a new Director increasing the size of the Board of Directors from five to six.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Mr. Dalsin is best known in Canada as the former Chairman of Convalo Health International, Corp. (“&lt;strong&gt;Convalo&lt;/strong&gt;”) and Patient Home Monitoring</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Appoints+Michael+Dalsin+as+Chairman+of+the+Board+of+Directors%3B+Increases+Size+of+Board+to+Six/24506444.html</guid>
   <pubDate>Mon, 17 Mar 2025 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16742673</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26513355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00287878</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
  <item>
   <title>Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six</title>
   <link>http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Appoints+Michael+Dalsin+as+Chairman+of+the+Board+of+Directors%3B+Increases+Size+of+Board+to+Six/24506444.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;NEW YORK, March  17, 2025  (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “&lt;strong&gt;Company&lt;/strong&gt;”) (TSXV: EVMT) ‎announces the appointment of Michael Dalsin as Chairman of the Board of Directors. Kenneth Kashkin, MD will take the role of Vice-Chairman. Bill Garbarini will retain his role as COO while stepping off the Board of Directors. Chris Heath was also appointed as a new Director increasing the size of the Board of Directors from five to six.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Mr. Dalsin is best known in Canada as the former Chairman of Convalo Health International, Corp. (“&lt;strong&gt;Convalo&lt;/strong&gt;”) and Patient Home Monitoring</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Evome+Medical+Technologies+Appoints+Michael+Dalsin+as+Chairman+of+the+Board+of+Directors%3B+Increases+Size+of+Board+to+Six/24506444.html</guid>
   <pubDate>Mon, 17 Mar 2025 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.16742673</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26513355</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208731</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EVMT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00287878</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.18962833</category>
   	  </item>
 </channel>
</rss>
